Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 15/20 | 0.50 |
| ▸ | THRA | P10827 | 14/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.37 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5377126 | 0.86 | CYP3A4 (0.40) | THRBTHRACYP3A4CYP2C9TSHR | |
| SCHEMBL5368768 | 0.86 | CYP3A4 (0.42) | THRBTHRACYP3A4CYP2C9TSHR | |
| SCHEMBL5374337 | 0.80 | CYP3A4 (0.47) | CYP3A4CYP2C9TSHRCYP2C19PRMT5 | |
| SCHEMBL5370938 | 0.78 | CYP3A4 (0.38) | THRBTHRACYP3A4CYP2C9TSHR | |
| SCHEMBL5385763 | 0.76 | CYP3A4 (0.43) | THRBTHRACYP3A4CYP2C9TSHR | |
| SCHEMBL5373734 | 0.76 | CYP3A4 (0.45) | THRBTHRACYP3A4CYP2C9TSHR | |
| SCHEMBL5373844 | 0.75 | CYP3A4 (0.45) | CYP3A4CYP2C9CYP2C19PRMT5WDR77 | |
| SCHEMBL5367073 | 0.74 | CYP3A4 (0.44) | CYP3A4CYP2C9TSHRCYP2C19PRMT5 | |
| SCHEMBL5411461 | 0.74 | APOBEC3G (0.40) | CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL5374494 | 0.73 | CYP3A4 (0.43) | THRBTHRACYP3A4CYP2C9TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |
| US-7189718-B2 | Non-nucleoside reverse transcriptase inhibitors | ROCHE PALO ALTO LLC (US) | 2007-03-13 | — | — | US | disclosed |